Stonepine Capital Management, LLC Aldeyra Therapeutics, Inc. Transaction History

Stonepine Capital Management, LLC

  • $158 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 16, 2022
SELL
$3.25 - $5.17 $650,000 - $1.03 Million
-200,000 Closed
0 $0
Q4 2021

Feb 14, 2022
BUY
$3.5 - $9.63 $700,000 - $1.93 Million
200,000 New
200,000 $800,000
Q4 2018

Feb 13, 2019
SELL
$7.26 - $13.29 $1.05 Million - $1.93 Million
-145,000 Closed
0 $0
Q3 2018

Nov 13, 2018
BUY
$6.8 - $14.35 $986,000 - $2.08 Million
145,000 New
145,000 $2 Million

Others Institutions Holding ALDX

# of Institutions
117
Shares Held
36.4M
Call Options Held
196K
Put Options Held
142K
View Full List

About Aldeyra Therapeutics, Inc.

ALDX Quotes by TradingView
  • Ticker ALDX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 58,323,100
  • Market Cap $283M
  • Description
  • Aldeyra Therapeutics, Inc., a biotechnology company, develops and commercializes medicines for immune-mediated ocular and systemic diseases. The company's lead product candidate is reproxalap, a reactive aldehyde species (RASP)modulator, which is in Phase III clinical trial for the treatment of dry eye diseases and allergic conjunctivitis. It al...
More about ALDX
Track This Portfolio

Track Stonepine Capital Management, LLC Portfolio

Follow Stonepine Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Stonepine Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Stonepine Capital Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email